Literature DB >> 9153531

Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion.

L Montermini1, A Richter, K Morgan, C M Justice, D Julien, B Castellotti, J Mercier, J Poirier, F Capozzoli, J P Bouchard, B Lemieux, J Mathieu, M Vanasse, M H Seni, G Graham, F Andermann, E Andermann, S B Melançon, B J Keats, S Di Donato, M Pandolfo.   

Abstract

We studied genotype-phenotype correlations in a group of 100 patients with typical Friedreich ataxia (FRDA), and in three groups of patients with atypical clinical presentations, including 44 Acadian FRDA, 8 late-onset FRDA (LOFA), and 6 FRDA with retained reflexes (FARR). All patients, except 3 with typical FRDA, carried two copies of the FRDA-associated GAA triplet repeat expansion. Overall, the phenotypic spectrum of FRDA appeared to be wider than defined by the currently used diagnostic criteria. Our study indicated the existence of several sources of variability in FRDA. Patients with larger GAA expansions tended to have earlier onset and were more likely to show additional manifestations of the disease. Mitotic instability of the expanded GAA repeats may partially account for the limited degree of correlation between expansion sizes as determined in lymphocytes and clinical parameters. Some clinical variants associated with specific FRDA haplotypes, such as Acadian FRDA and FARR, turned out to be unrelated to expansion sizes. No polymorphism in the frataxin coding sequence could be associated with these clinical variants.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9153531     DOI: 10.1002/ana.410410518

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  74 in total

Review 1.  Friedreich ataxia-update on pathogenesis and possible therapies.

Authors:  Max Voncken; Panos Ioannou; Martin B Delatycki
Journal:  Neurogenetics       Date:  2003-12-19       Impact factor: 2.660

2.  Has Progress Been Made in Progressive Myoclonic Epilepsy (EPM1)?

Authors:  M Scott Perry
Journal:  Epilepsy Curr       Date:  2015 Sep-Oct       Impact factor: 7.500

Review 3.  Friedreich ataxia: an overview.

Authors:  M B Delatycki; R Williamson; S M Forrest
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

4.  Clinical heterogeneity of recessive ataxia in the Mexican population.

Authors:  A Rasmussen; M Gómez; E Alonso; S I Bidichandani
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12       Impact factor: 10.154

5.  White matter changes in patients with friedreich ataxia after treatment with erythropoietin.

Authors:  Karl Egger; Christian Clemm von Hohenberg; Michael F Schocke; Charles R G Guttmann; Demian Wassermann; Marlene C Wigand; Wolfgang Nachbauer; Christian Kremser; Brigitte Sturm; Barbara Scheiber-Mojdehkar; Marek Kubicki; Martha E Shenton; Sylvia Boesch
Journal:  J Neuroimaging       Date:  2013-09-09       Impact factor: 2.486

6.  Utilisation of advance motor information is impaired in Friedreich ataxia.

Authors:  Louise A Corben; Martin B Delatycki; John L Bradshaw; Andrew J Churchyard; Nellie Georgiou-Karistianis
Journal:  Cerebellum       Date:  2011-12       Impact factor: 3.847

7.  Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development.

Authors:  R Mark Payne; P Melanie Pride; Clifford M Babbey
Journal:  Pediatr Cardiol       Date:  2011-03-01       Impact factor: 1.655

8.  Impairment in motor reprogramming in Friedreich ataxia reflecting possible cerebellar dysfunction.

Authors:  Louise A Corben; Martin B Delatycki; John L Bradshaw; Malcolm K Horne; Michael C Fahey; Andrew J Churchyard; Nellie Georgiou-Karistianis
Journal:  J Neurol       Date:  2009-12-03       Impact factor: 4.849

9.  Length-dependent structure formation in Friedreich ataxia (GAA)n*(TTC)n repeats at neutral pH.

Authors:  V N Potaman; E A Oussatcheva; Y L Lyubchenko; L S Shlyakhtenko; S I Bidichandani; T Ashizawa; R R Sinden
Journal:  Nucleic Acids Res       Date:  2004-02-20       Impact factor: 16.971

10.  Progressive GAA.TTC repeat expansion in human cell lines.

Authors:  Scott Ditch; Mimi C Sammarco; Ayan Banerjee; Ed Grabczyk
Journal:  PLoS Genet       Date:  2009-10-30       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.